Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-24 @ 9:19 PM
NCT ID:
NCT02896504
Eligibility Criteria:
Inclusion Criteria:
* For all participants
1. Female aged 20-70
2. Right handed as determined by the Edinburgh Inventory \[40\]
3. Proficient in English
* For Cancer patients
1. Had breast cancer surgery
2. Stage I, II, IIIa
3. Non metastatic cancer
4. Chemotherapy Patients: Scheduled to receive or receiving breast cancer chemotherapy with Anthracycline and/or Taxane
5. Hormonal Therapy Patients: Scheduled to receive or receiving hormonal therapy with Aromatase inhibitor
6. For patients recruited before adjuvant therapy: Adjuvant therapy starts at least 2 weeks after surgery
7. For patients recruited after adjuvant therapy started: Before completing/within 1 month post chemotherapy Within 4 months after starting hormonal therapy
Exclusion Criteria:
1. Symptoms for mild or severe depression as determined by a Patient Health Questionnaire (PHQ-8) score \>14
2. Significant impairment in ability to understand and analyze information as determined by a Folstein Mini-Mental State Exam score \<21.
3. Prior history of cancer (except breast cancer for breast cancer patients), trauma, neurological, psychiatric, physical or psychological diseases or other conditions that may influence nervous system structure and function
4. Current medication believed to affect cognitive/psychomotor function (i.e., opioid analgesics, anxiolytics or antidepressants)
5. History of alcohol, smoking and drug abuse
6. Transcranial Magnetic Stimulation or MRI contraindication
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
70 Years
Study:
NCT02896504
Study Brief:
Protocol Section:
NCT02896504